Furthermore, the treatment with DNA methyltransferase inhibitors (DNMTi) can enhance the cytotoxic potential of anti-tumoral CD8+ T cells [103], apparently by inducing a mechanism similar to viral mimicry in CD8+ T-cells, facilitating their activation and tumor-suppressing function. This evidence concerns the gene CD8A and neoplasm.